Exact Mass: 393.17874320000004

(-)-Tylocrebrine

(+/-)-Tylocrebrine

Tylophorine

(+/-)-Tylophorine

Fruquintinib

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

Branaplam

C78272 - Agent Affecting Nervous System

Erlotinib

[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine

Erlotinib hydrochloride (trade name Tarceva, Genentech/OSIP, originally coded as OSI-774) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. Similar to gefitinib, erlotinib specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase. It binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. Erlotinib has recently been shown to be a potent inhibitor of JAK2V617F activity. JAK2V617F is a mutant of tyrosine kinase JAK2, is found in most patients with polycythemia vera (PV) and a substantial proportion of patients with idiopathic myelofibrosis or essential thrombocythemia. The study suggests that erlotinib may be used for treatment of JAK2V617F-positive PV and other myeloproliferative disorders. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents

6'-Apiosyllotaustralin

2-{[6-({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-methylbutanenitrile

6-Apiosyllotaustralin is found in root vegetables. 6-Apiosyllotaustralin is a constituent of the roots of Manihot esculenta (cassava). Constituent of the roots of Manihot esculenta (cassava). 6-Apiosyllotaustralin is found in root vegetables.

Epoxyfumitremorgin C

8-methoxy-13-(2-methylprop-1-en-1-yl)-2-oxa-11,14,20-triazahexacyclo[12.7.0.0¹,³.0⁴,¹².0⁵,¹⁰.0¹⁶,²⁰]henicosa-4(12),5(10),6,8-tetraene-15,21-dione

Epoxyfumitremorgin C is from Aspergillus fumigatus. From Aspergillus fumigatus

(-)-Tylophorine

4,5,10,11-tetramethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2,4,6,8,10,12-heptaene

Adaphostin

adamantan-1-yl 4-{[(2,5-dihydroxyphenyl)methyl]amino}benzoate

C18H23N3O5S (393.13583480000005)

N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride

N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulphonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride

Daprodustat

2-(1,3-Dicyclohexyl-6-hydroxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamido)acetic acid

B - Blood and blood forming organs > B03 - Antianemic preparations C78275 - Agent Affecting Blood or Body Fluid Daprodustat (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor being developed for the treatment of anemia associated with chronic kidney disease.

gamma-Glutamylfelinylglycine

2-Amino-5-[[1-(carboxymethylamino)-3-(4-hydroxy-2-methylbutan-2-yl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C15H27N3O7S (393.1569632)

1H-Indole-3-carboxylic acid, 1-methyl-, (1-(2-((methylsulfonyl)amino)ethyl)-4-piperidinyl)methyl ester

1H-Indole-3-carboxylic acid, 1-methyl-, (1-(2-((methylsulphonyl)amino)ethyl)-4-piperidinyl)methyl ester

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists GR 113808 is a potent and highly selective 5-HT4?receptor antagonist (pKb= 8.8). GR 113808 shows 300-fold selectivity over 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2C and 5-HT3 receptors[1].

Lumateperone

1-(4-fluorophenyl)-4-{4-methyl-1,4,12-triazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16)-trien-12-yl}butan-1-one

N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

1-(2-Methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine

2-{4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}-2,3-dihydro-1H-isoindole-1,3-dione

Pentetic acid

[[(Carboxymethyl)imino]bis(1,2-ethanediylnitrilo)tetraacetic acid]

C14H23N3O10 (393.1383378)

Pirenperone

3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one

C22H27N5S (393.19870620000006)

2-{[(1r,2s)-2-Aminocyclohexyl]amino}-4-{[3-(2h-1,2,3-Triazol-2-Yl)phenyl]amino}pyrimidine-5-Carboxamide

2-[(2-Aminocyclohexyl)amino]-6-{[3-(2H-1,2,3-triazol-2-yl)phenyl]imino}-1,6-dihydropyrimidine-5-carboximidate

C19H23N9O (393.2025468)

10-(2-(Diethylamino)ethyl)-9(10H)-acridinone (4,5-dihydro-2-thiazolyl)hydrazone

(2-{9-[2-(4,5-dihydro-1,3-thiazol-2-yl)hydrazin-1-ylidene]-9,10-dihydroacridin-10-yl}ethyl)diethylamine

1-[5-(2-Cyclopropyl-5,7-dimethylimidazo[4,5-b]pyridin-3-ylmethyl)thiophen-2-yl]cyclopent-3-ene carboxylic acid

1-[5-({2-cyclopropyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl}methyl)thiophen-2-yl]cyclopent-3-ene-1-carboxylic acid

4-(2-Aminoethylamino)-3-[bis(carboxymethyl)amino]-3-(carboxymethyl)hexanedioic acid

4-[(2-aminoethyl)amino]-3-[bis(carboxymethyl)amino]-3-(carboxymethyl)hexanedioic acid

C14H23N3O10 (393.1383378)

Buxifoliadine B

Waltherione B

Acetylgynuramine

Gynuramine 19-O-acetate

An indole alkaloid isolated from a marine-derived fungal strain Aspergillus sydowii PFW1-13 and has been shown to exhibit cytotoxic activity.

H-GLU-VAL-PHE-OH

Glutamyl-valyl-phenylalanine

Pirenperone

D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Pirenperone (R 47465) is a 5-HT2 serotonin receptor antagonist. Pirenperone exhibits modest anxiolytic activity[1][2].

linustatin

Kealiinine C

4-O-demethylancistrocladine|4-O-demethylhamatine

Valistatin

CHEMBL464846

5-O-demethylhamatine

isoipanguline B

C21H31NO6

2-((6-O-(beta-D-apiofuranosyl)-beta-D-glucopyranosyl)oxy)-2-methylbutanenitrile

10-hydroxy-2,2,6,6,9-pentamethyl-3,4,6,7,8,9-hexahydro-2H-dipyrano[2,3-a;2,3-c]acridin-14-one|N-methyl-bicycloatalaphylline|N-Methylbicycloatalaphyllin|N-Methylbicycloatalaphylline

asperloxin A|circumdatin A

Voacangine 3-carbonitrile

Tyloindicine B

brevianamide L

oxepinamide G

6-[2-(1,1-dimethyl-allyl)-6-(3-methyl-but-2-enyl)-2,3-dihydro-1H-indol-3-ylmethylene]-piperazine-2,3,5-trione|Neo-echinulin

C20H27NO5S

ancistrogriffine C

Buxifoliadine E

Bocconoline

14-desoxy-13a-methyltylohirsutinidine

Tyloindicine A

N-Methylcycloatalaphylline A

6-(1-hydroxyethyl)-5,6-dihydrochelerythrine

(S)-3-((1,7-dihydro-7,7-dimethyl-2-(2-methylbut-3-en-2-yl)pyrano[2,3-g]indol-3-yl)methyl)piperazine-2,5-dione|talathermophilin C

C24H27NO4

oxiamycin

CHEMBL3125442

marmeline acetate|N-[2-acetoxy-2-[4-(3,3-dimethylallyloxy)]phenyl]ethylcinnamide

1-Piperazineacetamide, 4-((3,5-dimethoxy-4-hydroxy)dihydrocinnamoyl)-N-isopropyl-

Hydroxy-isocyclocelabenzin

Tylohirsutinidine

Hypoestestatin 2

jacobine-acetate

N-Methylatalaphyllin

6-Ethoxychelerythrine

Met Pro Phe

Phe Asn Asn

Phe Val Glu

Leu Phe Thr

Glu Phe Val

Pro Asp Tyr

Phe Glu Val

Thr His His

Asn Phe Asn

His Thr His

Phe Thr Leu

Leu Thr Phe

Asp Ile Phe

Phe Pro Met

His His Thr

Asn Asn Phe

Val Phe Glu

Val Ile Tyr

Met Ile Met

Ile Val Tyr

Thr Phe Leu

Pro Phe Met

Pro Met Phe

Phe Leu Thr

Asp Pro Tyr

DTXSID40875279

Pro Tyr Asp

Tyr Ile Val

SCHEMBL11799067

Phe Asp Ile

Ile Phe Asp

Val Glu Phe

Ile Asp Phe

Tyr Pro Asp

Phe Ile Asp

SCHEMBL12063254

C15H27N3O7S (393.1569632)

6-(1-Hydroxyethyl)-5,6-dihydrochelerythrine

AMG-073 HCl (Cinacalcet hydrochloride)

C16H27NO10

NCGC00380916-01_C16H27NO10_

Glu-Val-Phe

Ala Cys Asn Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

Ala Cys Ser Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

Ala Asn Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

Ala Asn Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

Ala Ser Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

Ala Ser Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

Cys Ala Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

Cys Ala Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

Cys Gly Lys Ser

(2S)-2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]-3-hydroxypropanoic acid

Cys Gly Asn Thr

(2S,3R)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxybutanoic acid

Cys Gly Gln Ser

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-4-carbamoylbutanamido]-3-hydroxypropanoic acid

Cys Gly Ser Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-hydroxypropanamido]hexanoic acid

Cys Gly Ser Gln

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-hydroxypropanamido]-4-carbamoylbutanoic acid

Cys Gly Thr Asn

(2S)-2-[(2S,3R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-hydroxybutanamido]-3-carbamoylpropanoic acid

Cys Lys Gly Ser

(2S)-2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}-3-hydroxypropanoic acid

Cys Lys Ser Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-hydroxypropanamido]acetic acid

Cys Asn Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]propanamido]-3-hydroxypropanoic acid

Cys Asn Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxybutanoic acid

Cys Asn Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]propanoic acid

Cys Asn Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]acetic acid

Cys Gln Gly Ser

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]acetamido}-3-hydroxypropanoic acid

Cys Gln Ser Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]acetic acid

Cys Ser Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]propanamido]-3-carbamoylpropanoic acid

Cys Ser Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]acetamido}hexanoic acid

Cys Ser Gly Gln

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]acetamido}-4-carbamoylbutanoic acid

Cys Ser Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]hexanamido]acetic acid

Cys Ser Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]propanoic acid

Cys Ser Gln Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]acetic acid

Cys Thr Gly Asn

(2S)-2-{2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]acetamido}-3-carbamoylpropanoic acid

Cys Thr Asn Gly

2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]acetic acid

Phe Gly Gly Asn

(2S)-2-(2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}acetamido)-3-carbamoylpropanoic acid

Phe Gly Asn Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-carbamoylpropanamido]acetic acid

Phe Asn Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]acetamido}acetic acid

Gly Cys Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]-3-hydroxypropanoic acid

Gly Cys Asn Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

Gly Cys Gln Ser

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

Gly Cys Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-hydroxypropanamido]hexanoic acid

Gly Cys Ser Gln

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

Gly Cys Thr Asn

(2S)-2-[(2S,3R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

Gly Phe Gly Asn

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]acetamido}-3-carbamoylpropanoic acid

Gly Phe Asn Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-carbamoylpropanamido]acetic acid

Gly Gly Phe Asn

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

Gly Gly Asn Phe

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

Gly Lys Cys Ser

(2S)-2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

Gly Lys Ser Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

Gly Asn Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

Gly Asn Phe Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-phenylpropanamido]acetic acid

Gly Asn Gly Phe

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]acetamido}-3-phenylpropanoic acid

Gly Asn Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

Gly Gln Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

Gly Gln Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

Gly Ser Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-sulfanylpropanamido]hexanoic acid

Gly Ser Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

Gly Ser Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]hexanamido]-3-sulfanylpropanoic acid

Gly Ser Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

Gly Thr Cys Asn

(2S)-2-[(2R)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

Gly Thr Asn Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

Phe Met Pro

Met Met Leu

Met Leu Met

Phe Pro Met

Lys Cys Gly Ser

(2S)-2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}-3-hydroxypropanoic acid

Lys Cys Ser Gly

2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]acetic acid

Lys Gly Cys Ser

(2S)-2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]-3-hydroxypropanoic acid

Lys Gly Ser Cys

(2R)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxypropanamido]-3-sulfanylpropanoic acid

Lys Ser Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]acetic acid

Lys Ser Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]acetamido}-3-sulfanylpropanoic acid

Asp Tyr Pro

Leu Asp Phe

Met Pro Phe

Met Met Ile

Asn Ala Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

Asn Ala Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

Asn Cys Ala Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]propanamido]-3-hydroxypropanoic acid

Asn Cys Gly Thr

(2S,3R)-2-{2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetamido}-3-hydroxybutanoic acid

Asn Cys Ser Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]propanoic acid

Asn Cys Thr Gly

2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]acetic acid

Asn Phe Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]acetamido}acetic acid

Asn Gly Cys Thr

(2S,3R)-2-[(2R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanamido]-3-hydroxybutanoic acid

Asn Gly Phe Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-phenylpropanamido]acetic acid

Asn Gly Gly Phe

(2S)-2-(2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}acetamido)-3-phenylpropanoic acid

Asn Gly Thr Cys

(2R)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxybutanamido]-3-sulfanylpropanoic acid

Asp Phe Ile

Phe Leu Asp

Phe Asp Leu

Asn Ser Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]propanamido]-3-sulfanylpropanoic acid

Asn Ser Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]propanoic acid

Asn Ser Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

Asn Thr Cys Gly

2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]acetic acid

Asn Thr Gly Cys

(2R)-2-{2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]acetamido}-3-sulfanylpropanoic acid

Leu Met Met

Met Phe Pro

Gln Cys Gly Ser

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]acetamido}-3-hydroxypropanoic acid

Gln Cys Ser Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]acetic acid

Gln Gly Cys Ser

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-sulfanylpropanamido]-3-hydroxypropanoic acid

Gln Gly Ser Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-hydroxypropanamido]-3-sulfanylpropanoic acid

Pro Met Phe

Gln Ser Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]acetic acid

Gln Ser Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]acetamido}-3-sulfanylpropanoic acid

Asp Leu Phe

Tyr Asp Pro

Pro Phe Met

Leu Phe Asp

Ser Ala Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

Ser Ala Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

Ser Cys Ala Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]propanamido]-3-carbamoylpropanoic acid

Ser Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]acetamido}hexanoic acid

Ser Cys Gly Gln

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]acetamido}-4-carbamoylbutanoic acid

Ser Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]hexanamido]acetic acid

Ser Cys Asn Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]propanoic acid

Ser Cys Gln Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]acetic acid

Ile Met Met

Ser Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-sulfanylpropanamido]hexanoic acid

Ser Gly Cys Gln

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

Ser Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}hexanamido]-3-sulfanylpropanoic acid

Ser Gly Gln Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

Ser Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-sulfanylpropanamido]acetic acid

Ser Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]acetamido}-3-sulfanylpropanoic acid

Ser Asn Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]propanamido]-3-sulfanylpropanoic acid

Ser Asn Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]propanoic acid

Ser Asn Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

Asp Phe Leu

Ser Gln Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]acetic acid

Ser Gln Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]acetamido}-3-sulfanylpropanoic acid

Ser Ser Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

Ser Ser Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

Glu Val Phe

Thr Cys Gly Asn

(2S)-2-{2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanoic acid

Thr Cys Asn Gly

2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetic acid

Thr Gly Cys Asn

(2S)-2-[(2R)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

Thr Gly Asn Cys

(2R)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

Thr Asn Cys Gly

2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetic acid

Thr Asn Gly Cys

(2R)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanoic acid

C20H22F3N3S (393.14864480000006)

N-Desmethyltrifluoperazine

Pentetic acid

Diethylenetriaminepentaacetic acid

C14H23N3O10 (393.1383378)

D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents D020011 - Protective Agents > D000931 - Antidotes

Tarceva

N-(3-ethylnylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine

6'-Apiosyllotaustralin

2-{[6-({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-methylbutanenitrile

Epoxyfumitremorgin C

8-methoxy-13-(2-methylprop-1-en-1-yl)-2-oxa-11,14,20-triazahexacyclo[12.7.0.0^{1,3}.0^{4,12}.0^{5,10}.0^{16,20}]henicosa-4(12),5,7,9-tetraene-15,21-dione

ascr#8

N-(6R-[3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy]-2E-heptenoyl)-4-aminobenzoic acid

A carboxamide resulting from the formal condensation of the carboxy group of ascr#7 with the amino group of 4-aminobenzoic acid. A metabolite of the nematode Caenorhabditis elegans, it is dauer inducing and strongly male attracting.

Ent-cinacalcet hydrochloride

bencynoate hydrochloride

[(1R,4S)-4-hydroxy-3-methylcyclopent-2-en-1-yl]methyl-trimethylazanium,iodide

(2S)-2-acetamido-N-[(2S)-1-[[(2S)-1-(4-nitroanilino)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]propanamide

7-FLUORO-3,4-DIHYDRO-4-[(5-ISOQUINOLINYLOXY)ACETYL]-1,3,3-TRIMETHYL-2(1H)-QUINOXALINONE

C24H28ClN3 (393.19716380000006)

Basic Violet 1

Urea, N-[(2-chloro-6,8-dimethyl-3-quinolinyl)methyl]-N-(2-methylphenyl)-N-2-propenyl- (9CI)

C23H24ClN3O (393.1607804)

Spirilene

H-Leu-OBzl.TosOH

H-Ile-ObzlTos

(S)-N-PHENYLACETYL-BETA-PHENYLALANINE

TERT-BUTYL 4-((4-(ETHOXYCARBONYL)-2-ETHOXYPHENOXY)METHYL)PIPERIDINE-1-CARBOXYLATE

2,6-BIS((3AS,8AR)-8,8A-DIHYDRO-3AH-INDENO[1,2-D]OXAZOL-2-YL)PYRIDINE

C25H19N3O2 (393.1477194)

Fmoc-D-Cha-OH

5,6-dimethoxy-2-(di-n-propylamino)indan maleate

Cinacalcet hydrochloride

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D057966 - Calcimimetic Agents C78275 - Agent Affecting Blood or Body Fluid > C2136 - Malignancy-Associated Hypercalcemia Inhibitor D000077264 - Calcium-Regulating Hormones and Agents

Norgestrienone

C21H28ClNO4 (393.1706758000001)

21-Amino-17-hydroxypregna-1,4-diene-3,11,20-trione hydrochloride

H-D-Leu-OBzl.TosOH

5-(6-(BENZYLOXY)NAPHTHALEN-2-YL)-2,2-DIMETHYL-5-NITRO-1,3-DIOXANE

4-Cyanophenyl 4-(6-acryloyloxyhexyloxy)benzoate

C20H19N5O4 (393.14369740000006)

methyl 2-[(3-cyanobenzoyl)amino]-3-(3-methoxypropyl)imidazo[4,5-b]pyridine-6-carboxylate

Loderix

C22H29Cl2NO (393.1626084)

O-[BIS(4-METHOXYPHENYL)PHOSPHINYL]-N-(TERT-BUTOXYCARBONYL)HYDROXYLAMINE

C19H24NO6P (393.13411740000004)

Fmoc-Cha-OH

C23H28BNO4 (393.21112780000004)

Benzyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropylcarbamate

3-(7-CYANO-5-(2-NITROPROPYL)INDOLIN-1-YL)PROPYL BENZOATE

Oxybutynin chloride

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D000890 - Anti-Infective Agents > D000892 - Anti-Infective Agents, Urinary > D008333 - Mandelic Acids D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Oxybutynin chloride is an oral active and competitive mAChR antagonist with Kis of 14.3 and 5.55 nM for specific [3H]NMS binding in the mouse bladder and cerebral cortex, respectively. Oxybutynin chloride inhibits vascular Kv channels in a manner independent of anticholinergic effect, with an IC50 value of 11.51 μM. Oxybutynin chloride reduces muscle spasm in the bladder and urinary tract, can be used in study of overactive bladder syndrome (OAB)[1][2]. Oxybutynin (chloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

(4-cyano-3-fluorophenyl) 4-(4-pentylcyclohexyl)benzoate

C25H28FNO2 (393.210396)

Dibenzo[f,h]pyrrolo[1,2-b]isoquinoline,9,11,12,13,13a,14-hexahydro-2,3,5,6-tetramethoxy-, (13aR)-

METHYL 4-(4-METHYL-5-(2-(TRIFLUOROMETHYL)PHENYL)-4H-1,2,4-TRIAZOL-3-YL)BICYCLO[2.2.2]OCTANE-1-CARBOXYLATE

C20H22F3N3O2 (393.1664028)

N-HYDROXY-4-(4-METHYL-5-(2-(TRIFLUOROMETHYL)PHENYL)-4H-1,2,4-TRIAZOL-3-YL)BICYCLO[2.2.2]OCTANE-1-CARBOXIMIDAMIDE

C19H22F3N5O (393.1776358)

Befiradol

C20H22ClF2N3O (393.1419376)

Befiradol (NLX-112) is a selective 5-HT1A receptor agonist.

(3-QUINUCLIDINYL)DI(2-METHYLPHENYL)CARBINOL HYDROCHLORIDE DIHYDRATE

Benafentrine

C24H28ClN3 (393.19716380000006)

methyl violet

n-me-val-obzl p-tosylate

PDE-9 inhibitor

C19H40BrNO2 (393.22422400000005)

Phenolphthalein anilide

C26H19NO3 (393.1364864000001)

Myristylpicoline

2,4-Dihydro-4-[4-[4-(4-hydroxylphenyl)piperazin-1-yl]phenyl]-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one

C17H23N5O4S (393.14706780000006)

BOC-THIONOLEU-1-(6-NITRO)BENZOTRIAZOLIDE

7-[2-[[(1S,2S)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]-1,3-dimethylpurine-2,6-dione,hydrochloride

C18H24ClN5O3 (393.15675840000006)

PRT-2607

C19H23N9O (393.2025468)

Nalbuphine Hydrochloride

C21H28ClNO4 (393.1706758000001)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

2-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)isoindoline-1,3-dione

C22H24BNO5 (393.1747444)

(2S)-(+)-1-BENZOYL-2-TERT-BUTYL-3-METHYL-4-IMIDAZOLIDINONE

Rimcazole dihydrochloride

C21H29Cl2N3 (393.1738414)

Rimcazole (BW 234U) dihydrochloride is a carbazole derivative that acts in part as a sigma (σ) receptor antagonist. Rimcazole dihydrochloride also binds with moderate affinity to the dopamine transporter and inhibit dopamine uptake. Rimcazole dihydrochloride can reduce locomotor activity and sensitization. Rimcazole dihydrochloride also can be used for the research of cancer[1][2][3][4].

2,6-BIS((3AR,8AS)-8,8A-DIHYDRO-3AH-INDENO[1,2-D]OXAZOL-2-YL)PYRIDINE

C25H19N3O2 (393.1477194)

tert-butyl {(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl}carbamate monooxalate monohydrate

C16H31N3O8 (393.2111046)

(S)-N-Fmoc-2-(6-Octenyl)Glycine

(S)-Cinacalcet hydrochloride

C22H22F3N.HCl (393.14710240000005)

C22H22F3N.HCl

Ethyl (2R,4S)-4-([1,1-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate

2-[(1-Benzyl-4-piperidinyl)methyl]-5,6-dimethoxy-1H-indene-1,3(2H)-dione

2-sec-butyl-4-{4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one

9H-Purine-9-acetic acid, 6-[bis[(1,1-diMethylethoxy)carbonyl]aMino]-

Dansyltryptamine

MOLYBDENUM (V) ISOPROPOXIDE

C15H35MoO5 (393.153841)

Fmoc-Gabapentin

but-2-enedioic acid,N,N-dimethyl-2-(11-methylidene-5,6-dihydrodibenzo[2,1-b:2,1-f][7]annulen-5-yl)ethanamine

5-Ethoxychelerthrine

(S)-N-FMOC-AMINO-2-CYCLOHEXYL-PROPANOIC ACID

(R)-N-Fmoc-2-(6-octenyl)glycine

C25H28ClNO (393.18593080000005)

N-Desmethyltamoxifen hydrochloride

4-(4-CBZ-PIPERAZIN-1-YL-METHYL)-2-TRIFLUOROMETHYLANILINE

C20H22F3N3O2 (393.1664028)

4-(3-(4-(1-methyl-1H-pyrazol-5-yl)phenylthio)phenyl)-tetrahydro-2H-pyran-4-carboxamide

C18H23N3O5S (393.13583480000005)

PF-4191834 (PF-04191834) is an orally active, noniron chelating, and non-redox inhibitor of the 5-Lipoxygenase (5-LOX) (IC50=229 nM), displays ~300-fold selectivity for 5-LOX over 12-LOX and 15-LOX, shows no activity toward the cyclooxygenase enzymes, and is effective in inflammation and pain[1].

N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors

Diphenhydramine salicylate

1-(2-Methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine

C22H27N5S (393.19870620000006)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

10-(2-(Diethylamino)ethyl)-9(10H)-acridinone (4,5-dihydro-2-thiazolyl)hydrazone

Fentanyl isothiocyanate

C23H27N3OS (393.18747320000006)

4-({(2E,6R)-6-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hept-2-enoyl}amino)benzoic acid

2-fluoro-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]benzamide

L-seryl-L-tyrosine 2-naphthylamide

1-(3,4-dihydro-2H-quinolin-1-yl)-2-[[1-(4-ethoxyphenyl)-2-imidazolyl]thio]ethanone

5-{[4-(9H-Fluoren-9-YL)piperazin-1-YL]carbonyl}-1H-indole

C26H23N3O (393.1841028)

2-({8-[(3R)-3-Aminopiperidin-1-YL]-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-YL}methyl)benzonitrile

C20H23N7O2 (393.1913138)

N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide

C26H23N3O (393.1841028)

5-Fluoro-1-[4-(4-phenyl-3,6-dihydropyridin-1(2H)-YL)butyl]quinazoline-2,4(1H,3H)-dione

5-{[4-(Aminooxy)butyl](methyl)amino}-5-deoxy-8-ethenyladenosine

C17H27N7O4 (393.2124422)

Daprodustat

ITI-722

Lumateperone

N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

Glutamylvalylphenylalanine

Lumateperone

1-(4-fluorophenyl)-4-{4-methyl-1,4,12-triazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16)-trien-12-yl}butan-1-one

C18H34O7P-3 (393.20420440000004)

N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

gamma-Glutamylfelinylglycine

C15H27N3O7S (393.1569632)

(9S,10S)-10-hydroxy-9-(phosphonatooxy)octadecanoate

(2E,4E,6E,8E,10E,12E,14E,16E,18E)-20-methoxy-4,8,13,17-tetramethyl-20-oxoicosa-2,4,6,8,10,12,14,16,18-nonaenoate

C25H29O4- (393.2065734)

2-((6-O-(beta-D-apiofuranosyl)beta-D-glucopyranosyl)oxy)-2-methylbutanenitrile

C23H23NO5-2 (393.15761480000003)

3-[(2E,4E,6E)-6,8-dimethyldeca-2,4,6-trienoyl]-1-hydroxy-5-(4-oxidophenyl)-2-oxopyridin-4-olate

(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-4-propylpyrrolidin-1-ium-2-carboxamide

C17H33N2O6S+ (393.20592180000006)

S-demethyllincomycin

C17H33N2O6S+ (393.20592180000006)

(2S,4R)-4-ethyl-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methylpyrrolidin-1-ium-2-carboxamide

C17H33N2O6S+ (393.20592180000006)

2-[[(3R)-3-(4-fluorophenyl)-3-(4-phenylphenoxy)propyl]-methylamino]acetic acid

C24H24FNO3 (393.17401259999997)

Talathermophilin C

A natural product found in Talaromyces thermophilus.

Leu-Phe-Asp

A tripeptide composed of L-leucine, L-phenylalanine and L-aspartic acid joined in sequence by peptide linkages.

3-[4-(1,3-Benzodioxol-5-ylmethyl)piperazin-1-yl]-1-phenylpyrrolidine-2,5-dione

N-[4-(4-morpholinyl)phenyl]-5-(2-nitrophenyl)-2-furancarboxamide

2-amino-3-cyano-5-oxo-1-spiro[7,8-dihydro-6H-1-benzopyran-4,4-piperidine]carboxylic acid (phenylmethyl) ester

1-[4-(4-Phenylmethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

C20H19N5O4 (393.14369740000006)

N-(3-imidazol-1-ylpropyl)-2-[(4-nitrobenzoyl)amino]benzamide

dafadine O

Asp-Leu-Phe

C18H23N3O5S (393.13583480000005)

2-[1-[[[(4-Methoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]-3-oxo-2-piperazinyl]acetic acid propan-2-yl ester

N-{(E)-[2,4,6-trioxo-1-(2,4,6-trimethylphenyl)tetrahydropyrimidin-5(2H)-ylidene]methyl}pyridine-4-carbohydrazide

C20H19N5O4 (393.14369740000006)

[1-[2-(2-Methylphenoxy)ethyl]-3-indolyl]-(4-methyl-1-piperazinyl)methanethione

C23H27N3OS (393.18747320000006)

11-(3-methoxypropyl)-3-((tetrahydrofuran-2-yl)methyl)-3H-pyrimido[5,4:4,5]pyrrolo[2,3-b]quinoxalin-4(11H)-one

C21H23N5O3 (393.18008080000004)

2,5-Dimethyl-3-furancarboxylic acid [2-(2-ethoxyanilino)-2-oxo-1-phenylethyl] ester

N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-3-(3-oxo-1,4-benzoxazin-4-yl)propanamide

2-[8-[(2,6-Dimethyl-4-morpholinyl)methyl]-1,3-dimethyl-2,6-dioxo-7-purinyl]acetic acid ethyl ester

C18H27N5O5 (393.2012092)

2-[4-(2-methoxyphenyl)-1-piperazinyl]-N-[4-(1-tetrazolyl)phenyl]acetamide

C20H23N7O2 (393.1913138)

2-[5-(2-Aminophenyl)-2-tetrazolyl]-1-[4-(4-methoxyphenyl)-1-piperazinyl]ethanone

C20H23N7O2 (393.1913138)

9-[3-(4-acetyl-3,5-dimethyl-1-pyrazolyl)-2-hydroxypropyl]-6-methyl-3,4-dihydro-2H-carbazol-1-one

Glu-Phe-Val

A tripeptide composed of L-glutamic acid, L-phenylalanine and L-valine joined in sequence by peptide linkages.

Indacaterol(1+)

C24H29N2O3+ (393.2178064)

Met-Pro-Phe

Met-Met-Leu

Met-Phe-Pro

Val-Glu-Phe

Asp-Ile-Phe

His-His-Thr

Met-Met-Ile

C21H28ClNO4 (393.1706758000001)

Nalbufina clorhidrato

3-[(4-Chlorophenyl)methylsulanyl]-4-methyl-5-undecyl-1,2,4-triazole

C21H32ClN3S (393.20053420000005)

4-Diethylamino-2-butynyl phenyl(cyclohexyl)glycolate hydrochloride

[(1S,2aR,8bR)-1-(hydroxymethyl)-2-(4-oxazolylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-fluorophenyl)methanone

(1S,5R)-N-cyclohexyl-7-[4-(4-fluorophenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

N-[[(2R,3S,4S)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1-(2-pyridin-3-ylacetyl)azetidin-2-yl]methyl]acetamide

N-[[(2S,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-methylpyridine-2-carboxamide

(3E)-1-[3-(dimethylamino)propyl]-5-fluoro-3-[(5-methoxy-1H-indol-3-yl)methylidene]indol-2-one

2-(diphenylmethoxy)-N,N-dimethylethanaminium 2-hydroxybenzoate

N-[(2R,3S,6S)-6-[2-[3-(dimethylamino)propylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-fluorobenzamide

N-[(2R,3S,6R)-6-[2-[3-(dimethylamino)propylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-fluorobenzamide

N-[(2S,3S,6S)-6-[2-[3-(dimethylamino)propylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-fluorobenzamide

1-(2-fluorophenyl)-3-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]urea

1-(2-fluorophenyl)-3-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]urea

1-(2-fluorophenyl)-3-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]urea

1-(2-fluorophenyl)-3-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]urea

1-(4-fluorophenyl)-3-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea

1-(4-fluorophenyl)-3-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea

N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-propanoyl-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]pyridine-4-carboxamide

N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-(1-oxo-2-pyridin-4-ylethyl)-3-phenyl-2-azetidinyl]methyl]cyclobutanecarboxamide

N-[[(2S,3S,4S)-4-(hydroxymethyl)-1-(1-oxo-2-pyridin-4-ylethyl)-3-phenyl-2-azetidinyl]methyl]cyclobutanecarboxamide

N-[[(2R,3R,4R)-4-(hydroxymethyl)-1-(1-oxo-2-pyridin-4-ylethyl)-3-phenyl-2-azetidinyl]methyl]cyclobutanecarboxamide

N-[[(2S,3R,4R)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-methyl-2-pyridinecarboxamide

N-[[(2R,3R,4S)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1-(2-pyridin-3-ylacetyl)azetidin-2-yl]methyl]acetamide

N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1-(2-pyridin-3-ylacetyl)azetidin-2-yl]methyl]acetamide

N-[[(2R,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-methylpyridine-2-carboxamide

(1R,9S,10S,11S)-10-(hydroxymethyl)-5-phenyl-11-(piperidine-1-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

4-[4-[(1S,5R)-3-(1-oxo-2-phenylethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C26H23N3O (393.1841028)

[(1S)-1-ethylsulfonyl-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

N-(2-hydroxyphenyl)-N-[(E)-[(E)-3-phenylprop-2-enylidene]amino]octanediamide

N-[(2S,3R,6R)-6-[2-[3-(dimethylamino)propylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-fluorobenzamide

N-[(2S,3R,6S)-6-[2-[3-(dimethylamino)propylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-fluorobenzamide

N-[(2S,3S,6R)-6-[2-[3-(dimethylamino)propylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-fluorobenzamide

N-[(2R,3R,6S)-6-[2-[3-(dimethylamino)propylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-fluorobenzamide

N-[(2R,3R,6R)-6-[2-[3-(dimethylamino)propylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-fluorobenzamide

1-(2-fluorophenyl)-3-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]urea

1-(2-fluorophenyl)-3-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]urea

1-(2-fluorophenyl)-3-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]urea

1-(2-fluorophenyl)-3-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]urea

1-(4-fluorophenyl)-3-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea

1-(4-fluorophenyl)-3-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea

N-[[(2S,3S,4R)-4-(hydroxymethyl)-1-propanoyl-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]pyridine-4-carboxamide

N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-(1-oxo-2-pyridin-4-ylethyl)-3-phenyl-2-azetidinyl]methyl]cyclobutanecarboxamide

N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-(1-oxo-2-pyridin-4-ylethyl)-3-phenyl-2-azetidinyl]methyl]cyclobutanecarboxamide

N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-(1-oxo-2-pyridin-4-ylethyl)-3-phenyl-2-azetidinyl]methyl]cyclobutanecarboxamide

N-[[(2R,3S,4S)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-methyl-2-pyridinecarboxamide

N-[[(2R,3R,4R)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-methyl-2-pyridinecarboxamide

N-[[(2S,3S,4S)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-methyl-2-pyridinecarboxamide

N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1-(2-pyridin-3-ylacetyl)azetidin-2-yl]methyl]acetamide

N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-methylpyridine-2-carboxamide

N-[[(2R,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-methylpyridine-2-carboxamide

N-[[(2R,3S,4S)-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinyl]methyl]-N-methylacetamide

N-[[(2S,3R,4R)-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinyl]methyl]-N-methylacetamide

[(1R,2aS,8bS)-1-(hydroxymethyl)-2-(4-oxazolylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-fluorophenyl)methanone

1-[(1R,2aR,8bR)-2-[2-(dimethylamino)-1-oxoethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-2-phenylethanone

(1S,9R,10R,11R)-10-(hydroxymethyl)-5-phenyl-11-(piperidine-1-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

[(1R)-1-ethylsulfonyl-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol

[(1R)-1-ethylsulfonyl-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

Phe-Asp-Leu

Asn-Phe-Asn

Asp-Pro-Tyr

His-Thr-His

Phe-Ile-Asp

Phe-Pro-Met

Pro-Asp-Tyr

Pro-Phe-Met

Thr-His-His

Tyr-Asp-Pro

Asn-Asn-Phe

Asp-Phe-Ile

Asp-Phe-Leu

Asp-Tyr-Pro

Ile-Asp-Phe

Ile-Met-Met

Ile-Phe-Asp

Leu-Asp-Phe

Leu-Met-Met

Met-Ile-Met

Met-Leu-Met

Phe-Asn-Asn

Phe-Asp-Ile

Phe-Glu-Val

Phe-Leu-Asp

Phe-Met-Pro

Phe-Val-Glu

Pro-Met-Phe

Pro-Tyr-Asp

Tyr-Pro-Asp

Val-Phe-Glu

C18H34O7P-3 (393.20420440000004)

beta-D-Tyvp2Me-(1->3)-beta-D-GalpN6,OMe2

C17H31NO9 (393.1998716)

(9S,10R)-10-hydroxy-9-(phosphonatooxy)octadecanoate

1-azocanyl-[(2R,4R)-2-(4-hydroxybutoxy)-4-thiophen-2-yl-3,4-dihydro-2H-pyran-6-yl]methanone

C21H31NO4S (393.19736860000006)

4-(diethylamino)but-2-yn-1-yl (2S)-cyclohexyl(hydroxy)phenylacetate hydrochloride

Cyclohexyl 2-methyl-4-thiophen-2-yl-3,4-dihydropyrimido[1,2-a]benzimidazole-3-carboxylate

(2,5-Dioxopyrrolidin-1-yl) 4-(3,6-diaminoacridin-10-ium-10-yl)butanoate

C21H21N4O4+ (393.1562726)

Tridecanal O-2,3,4,5,6-pentafluorobenzyloxime

C20H28F5NO (393.2090938)

Erlotinib

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents

GR113808

1H-Indole-3-carboxylic acid, 1-methyl-, (1-(2-((methylsulfonyl)amino)ethyl)-4-piperidinyl)methyl ester

6-Apiosyllotaustralin

C16H28NO8P (393.15524580000005)

LPC 8:3;O

ST 18:3;O5;Gly

ST 19:2;O4;Gly

ST 18:4;O2;Tau

(R)-Oxybutynin (hydrochloride)

(R)-Oxybutynin hydrochloride, a (R)-isomer of Oxybutynin hydrochloride, is an orally active muscarinic receptor antagonist. (R)-Oxybutynin hydrochloride has antimuscarinic, antispasmodic and anticholinergic activity, competitively antagonizes Carbachol-induced contractions. (R)-Oxybutynin hydrochloride can be used for researching incontinence due to neurogenic bladder dysfunction[1][2][3]. (R)-Oxybutynin (hydrochloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

Agomelatine (L(+)-Tartaric acid)

C19H23NO8 (393.1423598)

Agomelatine L(+)-Tartaric acid (S-20098 L(+)-Tartaric acid) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine L(+)-Tartaric acid is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].

AKT Kinase Inhibitor (hydrochloride)

C16H20ClN7O3 (393.131608)

AKT Kinase Inhibitor hydrochloride is an Akt kinase inhibitor with anti-tumor activity[1]. AKT Kinase Inhibitor (hydrochloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

4-[(2,6-dimethyl-1,2,4a,5,8,8a-hexahydronaphthalen-1-yl)(hydroxy)methylidene]-5-hydroxy-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

(2s)-20-hydroxy-10,18-dimethoxy-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16,18,20-heptaene-7,15-dione

{7-[(2-methylbut-2-enoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl}methyl 3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

7-benzyl-6,10-dihydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1,3,5,11,13-pentaen-9-one

5,10,11-trimethoxy-20-methyl-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-6-ol

10,19-dimethoxy-7,15-dioxo-6,14,22λ⁵-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁷,²²]docosa-1(22),8,10,12,16,18,20-heptaen-22-ylium-16-olate